Literature DB >> 178290

Mixed tumors of the salivary glands. Growth pattern and recurrence.

F Naeim, M I Forsberg, J Waisman, W F Coulson.   

Abstract

In 112 patients with mixed tumors of the salivary glands, 94 tumors were located in parotid glands, 11 in submandibular salivary glands, and 7 in monor palatal salivary glands. Capsular ingrowth, a characteristic growth pattern, may explain the frequency of multilobulation and capsular defects in these tumors, particularly those of long standing. The capsular thickness, the extent of fibrosis with stromal hyalinization, and the degree of lymphocytic infiltration within and around the capsule, were associated with cellularity of the tumors. Thus, 69% of the hypocellular neoplasms had incomplete capsules, and only 13% showed moderate to substantial lymphocytic infiltration; corresponding figures for hypercellular tumors were 22% and 42%, respectively. Of the recurrent lesions, 61% were hypocellular; 11% of the hypercellular tumors recurred. Incomplete resection, hypocellularity, and incomplete encapsulation were considered to be the major factors in recurrence.

Entities:  

Mesh:

Year:  1976        PMID: 178290

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

1.  Clinicopathologic Characteristics and Prognostic Factors of Primary and Recurrent Pleomorphic Adenoma: A Single Institution Retrospective Study of 705 Cases.

Authors:  Bayan Alzumaili; Bin Xu; Maelle Saliba; Abderhman Abuhashem; Ian Ganly; Ronald Ghossein; Nora Katabi
Journal:  Am J Surg Pathol       Date:  2021-11-15       Impact factor: 6.298

2.  Pleomorphic adenomas of the salivary glands: retrospective multicentric study of 130 cases with emphasis on histopathological features.

Authors:  Maria Luiza Diniz de Sousa Lopes; Keila Martha Amorim Barroso; Águida Cristina Gomes Henriques; Jean Nunes Dos Santos; Manoela Domingues Martins; Lélia Batista de Souza
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-12       Impact factor: 2.503

3.  Endoscope-assisted submandibular sialadenectomy: a review of outcomes, complications, and ethical concerns.

Authors:  Poramate Pitak-Arnnop; Niels Christian Pausch; Kittipong Dhanuthai; Kraison Sappayatosok; Pichit Ngamwannagul; Ute Bauer; Robert Sader; Alexander D Rapidis; Christian Hervé; Alexander Hemprich
Journal:  Eplasty       Date:  2010-05-21

4.  Pleomorphic adenoma of the parotid gland: a 13-year experience of consequent management by lateral or total parotidectomy.

Authors:  Orlando Guntinas-Lichius; Carsten Kick; J Peter Klussmann; Markus Jungehuelsing; Eberhard Stennert
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-22       Impact factor: 2.503

5.  Imaging characteristics of recurrent pleomorphic adenoma of the parotid gland.

Authors:  G Moonis; P Patel; Y Koshkareva; J Newman; L A Loevner
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

6.  Endoscope-assisted resection of nonneoplastic space-occupying lesion in oral and maxillofacial areas.

Authors:  Yanan Li; Runqi Xue; Qingguo Lai; Bingbing Xu; Kuifeng Yuan; Xiaopeng Tang; Jiangbo Ci; Shaolong Sun; Zhichao Zhang
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

Review 7.  Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables.

Authors:  Pavel Dulguerov; Jelena Todic; Marc Pusztaszeri; Naif H Alotaibi
Journal:  Front Surg       Date:  2017-05-15

8.  Clinical manifestations of recurrent parotid pleomorphic adenoma.

Authors:  Myung-Whan Suh; J Hun Hah; Seong Keun Kwon; Young-Ho Jung; Tack-Kyun Kwon; Kwang Hyun Kim; Myung-Whun Sung
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

9.  Comparative Study of Qualitative and Quantitative Analyses of Contrast-Enhanced Ultrasound and the Diagnostic Value of B-Mode and Color Doppler for Common Benign Tumors in the Parotid Gland.

Authors:  Meiying Yan; Dong Xu; Liyu Chen; Lingyan Zhou
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

10.  Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise.

Authors:  M McGurk; B L Thomas; A G Renehan
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.